According to the latest study results, the Corona vaccine from Moderna is also effective in children from 12 years of age.
The company announced on Tuesday.
According to the company, the corona * vaccine from the US company Moderna is also highly effective for children and adolescents from the age of twelve.
The vaccine showed an effectiveness of 100 percent in a clinical study with participants between the ages of twelve and 17 according to the common definition of the disease, Moderna said on Tuesday.
Moderna vaccine is well tolerated by children and adolescents
The vaccine is also safe and well tolerated by children and adolescents.
Accordingly, “no significant safety concerns were identified” in the age group.
According to Moderna, this is based on the results of a study with more than 3,700 participants between the ages of 12 and under 18 years.
None of them developed Covid 19 disease after a full vaccination.
The vaccine was well tolerated.
However, the results have not yet been reviewed by experts or published in a specialist journal.
Moderna wants to apply for emergency approval for corona vaccine
For this reason, Moderna wants to submit applications for approval of the vaccine for this age group to the US FDA and to authorities worldwide at the beginning of June.
The Moderna vaccine has so far received emergency approval for adults in the USA and the EU.
Moderna is aiming for European vaccine approval for children and adolescents aged 12 to 17 years.
An application to the EU Medicines Agency (EMA) in Amsterdam is planned for the beginning of next month.
The French-born Moderna CEO Stéphane Bancel said of the French Sunday newspaper
Le Journal du Dimanche
, as reported by the dpa news agency.
In the USA, the corona vaccine from Biontech-Pfizer was approved for children and adolescents between the ages of twelve and 15 on May 10. Until then, the vaccine had emergency approval for adolescents aged 16 and over and for adults. An application for admission for children and adolescents from the age of twelve is also pending in the EU.
(AFP / dpa / ml)
* Merkur.de is an offer from IPPEN.MEDIA.